SJSamuel L Johnston

Samuel L Johnston

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samuel L Johnston has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Alessandro Giaj Levra

    British Heart Foundation Center of Research Excellence (B.W., C.B., A.G.L., L.C., N.C., A. White, K.L., E.T., A. Winarski, R.O.F., M.M., T.R., P.H.K., S.N., M.G.M., S.V., M.B., E.J.R.v.B., M.R.D., M.C.W., D.E.N.), University of Edinburgh, Edinburgh, United Kingdom

    1 shared publication
  • Alex J Cuskey

    Division of Cardiovascular Medicine, Division of Cardiology, Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa , 200 Hawkins Drive, Iowa City, IA 52242

    1 shared publication
  • Artur Fedorowski

    Department of Cardiology Karolinska University Hospital Stockholm Sweden

    1 shared publication
  • Arwa Aburizik

    Division of Hematology-Oncology and Bone Marrow Transplant, Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa , Iowa City, IA

    1 shared publication
  • Avinash Mudireddy

    The Iowa Initiative for Artificial Intelligence, Iowa Institute for Biomedical Imaging, University of Iowa , Iowa City, IA

    1 shared publication
  • B. Hygriv Rao

    KIMS Hosp, Dept Cardiol, Hyderabad, India

    1 shared publication

Latest Publications

  • Open Access

    The hope and the hype of artificial intelligence for syncope management

    by Samuel L Johnston, E John Barsotti, Constantinos Bakogiannis, Artur Fedorowski, Fabrizio Ricci, Eric G Heller, Robert S Sheldon, Richard Sutton, Win-Kuang Shen, Venkatesh Thiruganasambandamoorthy, et al.

    Aims: Syncope remains a diagnostic challenge despite advancements in testing and treatment. Cardiac syncope is an independent predictor of mortality and can be difficult to distinguish from other causes of transient loss of consciousness (TLOC). This paper explores whether artificial intelligence (AI) can improve the evaluation and management of patients with syncope. Methods and results: We conducted a literature review and incorporated the opinions of experts in the fields of syncope and AI. The cause of TLOC is often unclear, hospitalization criteria are ambiguous, diagnostic tests are frequently non-informative, and assessments are costly. Patients are left with unanswered questions and limited guidance. Artificial intelligence (AI) has the potential to optimize syncope evaluation by processing large data sets, detecting imperceptible patterns, and assisting clinicians. However, AI has limitations, including errors, lack of human empathy, and uncertain clinical utility. Liability issues further complicate its integration. We present three viewpoints: (i) AI is crucial for advancing syncope management; (ii) AI can enhance the patient experience; and (iii) AI in syncope care is inevitable. Conclusion: Artificial intelligence may improve syncope diagnosis and management, particularly through machine learning–based test interpretation and wearable device data. However, it has yet to surpass human clinical judgment in complex decision-making. Current challenges include gaps in understanding syncope mechanisms, AI interpretability, generalizability, and clinical integration. Standardized diagnostic approaches, real-world validation, and curated data sets are essential for progress. Artificial intelligence may enhance efficiency and communication but raises concerns regarding confidentiality, bias, inequities, and legal implications.